Investing.com - Incyte (NASDAQ: INCY) reported first quarter EPS of $0.64, $0.18 worse than the analyst estimate of $0.82. Revenue for the quarter came in at $880.89M versus the consensus estimate of $925M.
Guidance
Incyte sees FY 2024 revenue of $2.69B-$2.75B versus the analyst consensus of $4.12B.
Incyte's stock price closed at $52.56. It is down -11.16% in the last 3 months and down -30.24% in the last 12 months.
Incyte saw 1 positive EPS revisions and 4 negative EPS revisions in the last 90 days. See Incyte's stock price’s past reactions to earnings here.
According to InvestingPro, Incyte's Financial Health score is "great performance".
Check out Incyte's recent earnings performance, and Incyte's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar